The evidence
- A timestamped portfolio snapshot
- The version of the mandate used
- Rationale, costs, and counter-evidence
SigmaX Capital / Capital
A compelling investment idea still has to fit the mandate. SigmaX Capital brings policy, evidence, and the person who decides into the same review — built on the AIgenTXS governed-action architecture.
Why this workflow needs a record
Cash, concentration, client objectives, and decision rights change what a team can do next. Keep the proposed allocation attached to those constraints, including the evidence that argues against it. A clearer record helps the reviewer distinguish a strong thesis from a permitted action.
Inside the workflow
Choose a scenario to inspect the proposed action, governing rule, evidence, and person responsible.
The proposed action
Illustrative workflow. No live action.
An interactive policy example
Adjust one sample input, declare the evidence, and record a simulated approval. A boundary failure remains a failure even when approval is checked.
Sample concentration ceiling15%
The projected position exceeds the sample mandate.
Illustrative inputs and one simplified policy rule. Calculated in this browser; no upload, stored decision record, provider call, or external action. This is not a deployed industry workflow.
For the full capital calculation using your own figures, try the SigmaX portfolio check.
What stays attached
The named human owns the capital decision. AI analysis does not inherit trading or allocation authority.
The current capital surface records checks and review state. SigmaX does not custody assets, place trades, transfer funds, or route customer capital.
Start with one workflow
Tell us what your team needs to govern, which evidence matters, and who owns the decision.
AIgenTXS’s mandate-to-effect architecture is implemented and tested in-repository with synthetic fixtures. Product runtime deployment, customer use, and independent attestation are separate milestones.